Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-cell Depletion in Unrelated Donor Marrow Transplantation
NCT00003187Phase 3Completed
- Sponsor
- Virginia Commonwealth University
- Start
- May 1995
- Primary completion
- Feb 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of T10B9.1A-31 in leukemia, lymphoma and myelodysplastic syndrome (MDS) (2 arms), sponsored by Virginia Commonwealth University. Primary endpoint: Disease Free Survival. Started May 1995; status: completed.
02
Drugs
T10B9.1A-31
03
Conditions
leukemialymphomamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00003187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003187.